S&P 500
(0.00%) 5 187.67 points
Dow Jones
(0.44%) 39 056 points
Nasdaq
(-0.18%) 16 303 points
Oil
(0.23%) $79.17
Gas
(-0.64%) $2.17
Gold
(-0.26%) $2 316.20
Silver
(-0.06%) $27.59
Platinum
(0.06%) $985.20
USD/EUR
(0.09%) $0.930
USD/NOK
(0.11%) $10.91
USD/GBP
(0.11%) $0.800
USD/RUB
(0.34%) $91.75

リアルタイムの更新: Solara Active Pharma [SOLARA.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-09)

Expected move: +/- 6.60%

最終更新日時8 5月 2024 @ 19:00

-1.49% INR 505.40

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 19:00):

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India...

Stats
本日の出来高 216 633
平均出来高 580 080
時価総額 18.19B
EPS INR0 ( 2024-02-14 )
次の収益日 ( INR0 ) 2024-05-09
Last Dividend INR3.00 ( 2021-08-18 )
Next Dividend INR0 ( N/A )
P/E -5.90
ATR14 INR0.690 (0.14%)

ボリューム 相関

長: 0.19 (neutral)
短: -0.99 (very strong negative)
Signal:(42.775) Neutral

Solara Active Pharma 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Solara Active Pharma 相関 - 通貨/商品

The country flag -0.31
( neutral )
The country flag -0.38
( neutral )
The country flag -0.34
( neutral )
The country flag -0.43
( neutral )
The country flag -0.28
( neutral )
The country flag 0.24
( neutral )

Solara Active Pharma 財務諸表

Annual 2022
収益: INR14.44B
総利益: INR6.55B (45.37 %)
EPS: INR-6.16
FY 2022
収益: INR14.44B
総利益: INR6.55B (45.37 %)
EPS: INR-6.16
FY 2022
収益: INR12.31B
総利益: INR5.33B (43.29 %)
EPS: INR-16.22
FY 2021
収益: INR16.17B
総利益: INR8.47B (52.40 %)
EPS: INR69.00

Financial Reports:

No articles found.

Solara Active Pharma Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Solara Active Pharma Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.729 - No dividend growth expected in the near future
Information
First Dividend INR5.00 2019-08-06
Last Dividend INR3.00 2021-08-18
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 4 --
Total Paid Out INR14.00 --
Avg. Dividend % Per Year 0.13% --
Score 0.73 --
Div. Sustainability Score 0
Div.Growth Potential Score 1.729
Div. Directional Score 0.449 --
Next Divdend (Est)
(2024-12-02)
INR0 Estimate 0.00 %
Dividend Stability
0.05 Very Bad
Dividend Score
0.73
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2019 INR5.00 1.62%
2020 INR6.00 1.41%
2021 INR3.00 0.25%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSB.NS No Dividend Player 2023-07-04 Sporadic 14 0.77%
KCP.NS Dividend Junior 2023-08-10 Annually 23 0.55%
EIMCOELECO.NS Dividend Knight 2023-06-16 Annually 23 0.80%
AGARIND.NS Ex Dividend Junior 2023-09-08 Annually 11 0.44%
SUMICHEM.NS Dividend Junior 2023-07-20 Annually 5 0.17%
NATCOPHARM.NS Dividend Junior 2023-08-22 Semi-Annually 29 0.68%
HITECHCORP.NS Dividend Junior 2023-06-30 Annually 17 0.30%
CANBK.NS Dividend Junior 2023-06-14 Sporadic 22 1.58%
RICOAUTO.NS Dividend Junior 2023-09-22 Annually 22 0.54%
L&TFH.NS Dividend Junior 2023-07-21 Annually 12 0.77%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.2191.500-4.38-6.57[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM-0.2761.500-4.18-6.27[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM-1.6071.000-1.706-1.706[3 - 30]
operatingCashFlowPerShareTTM43.402.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM43.402.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.3421.0007.647.64[0.2 - 0.8]
operatingProfitMarginTTM-0.1101.000-4.20-4.20[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-0.832

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-6.081.000-0.7150[1 - 100]
returnOnEquityTTM-0.2762.50-2.69-6.27[0.1 - 1.5]
freeCashFlowPerShareTTM43.402.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM43.402.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1111.0009.720[0.1 - 0.5]
Total Score1.729

Solara Active Pharma

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。